Advanced glycation end products and diabetic retinopathy.
about
Primary retinal cultures as a tool for modeling diabetic retinopathy: an overviewThe role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.Diabetic Retinopathy-Update on Prevention Techniques, Present Therapies, and New Leads.Novel drugs and their targets in the potential treatment of diabetic retinopathy.Prospectives for gene therapy of retinal degenerationsProtective effects of SIRT1 in patients with proliferative diabetic retinopathy via the inhibition of IL-17 expressionAntioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina.AGEs, contributors to placental bed vascular changes leading to preeclampsia.Biomarkers in diabetic retinopathy and the therapeutic implications.Effect of diet-derived advanced glycation end products on inflammation.Molecular characterization of glycation-associated skin ageing: an alternative skin model to study in vitro antiglycation activity of topical cosmeceutical and pharmaceutical formulations.Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises.Simultaneous quantitative profiling of 20 isoprostanoids from omega-3 and omega-6 polyunsaturated fatty acids by LC-MS/MS in various biological samples.Diabetes-induced oxidative stress in the vitreous humorTherapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.Stress responses of human retinal pigment epithelial cells to glyoxal.The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.Effect of the blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced diabetic retinopathy in rats.Activation of Macrophages and Microglia by Interferon-γ and Lipopolysaccharide Increases Methylglyoxal Production: A New Mechanism in the Development of Vascular Complications and Cognitive Decline in Type 2 Diabetes Mellitus?
P2860
Q27008921-8321AF71-CBC9-4462-BBF9-E17C099E503AQ33683197-E2397C31-27DA-4E2D-93D7-571F646AD8A0Q34553087-FCA08140-9898-4A91-8320-16717E3E985BQ34688209-E5851AB9-ECEF-4AF8-A916-95CC4730D367Q36108106-9DCBD9C1-830D-40AA-A0C4-954FD220F470Q36502289-50F2A77C-0260-4933-92A5-34506433DAC1Q37645117-DE413694-8E01-44ED-B98A-F6337FBE0A98Q38116590-FABED505-6CA4-4B0A-84A5-3F69B49FABB3Q38169142-20E20CFE-AA91-4133-A35B-8BF7E9011598Q38588208-87478A3E-ECAC-4840-880E-EB3805E000D8Q38846666-6EF0DA3C-AA94-4EC2-8145-40B75235F1ECQ38956425-0BA1E813-4D67-4C08-8109-2C9016FFEDCBQ41062855-6973CC82-83AD-411B-8CEE-A8A073C8C560Q41778258-C7CED445-3B13-4DB1-B988-30A3A681AD52Q42373000-5F64BE3A-36B2-45CF-AEE0-A9F7A514A94AQ46502389-96BED487-0089-46E6-9EE6-7DFC8C9B1C02Q48308877-3B63EC9B-18CF-444C-8BD9-08F888FA2E6DQ50220747-C39B022A-2BD9-4565-8A16-ADE37FDF556FQ53244774-A9182B0E-D5FF-498C-BD32-B8103A3BA93F
P2860
Advanced glycation end products and diabetic retinopathy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advanced glycation end products and diabetic retinopathy.
@en
Advanced glycation end products and diabetic retinopathy.
@nl
type
label
Advanced glycation end products and diabetic retinopathy.
@en
Advanced glycation end products and diabetic retinopathy.
@nl
prefLabel
Advanced glycation end products and diabetic retinopathy.
@en
Advanced glycation end products and diabetic retinopathy.
@nl
P2860
P1433
P1476
Advanced glycation end products and diabetic retinopathy.
@en
P2093
Ross Milne
Seymour Brownstein
P2860
P2888
P304
P356
10.1007/S00726-011-1071-3
P577
2011-09-11T00:00:00Z